Cresco acted as lead counsel in the +/- €10M Seed Investment round, led by imec.xpand and Kurma Partners.
Axithra is a digital medical technology company focused on the development of a platform for Therapeutic Drug Monitoring, spun off by imec and the University of Ghent. Axithra will build on the unique and IP-protected technology of both research institutes.
The Cresco deal team assisting Axithra and the investors consisted of Olivier Van Raemdonck, Elske Bleeker and Veerle Brusseleers.
More information on this transaction can be found in De Tijd.
For any further information or questions, please contact Olivier Van Raemdonck or Elske Bleeker.